InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: None

Wednesday, 10/18/2017 9:23:00 AM

Wednesday, October 18, 2017 9:23:00 AM

Post# of 403224
MAJOR DIFFERENCE BETWEEN PR's:

Oct 2nd PR:
"...today announces that the last patient has completed study treatment in the Company’s Phase 2 clinical trial of Brilacidin for the prevention and treatment of severe Oral Mucositis (OM) in patients undergoing chemoradiation for Head and Neck Cancer. A total of 61 patients were enrolled in the double-blinded study."

Oct 18th PR:
"...is pleased to report that all patients participating in the Phase 2 trial of Brilacidin-OM for the prevention and treatment of Oral Mucositis (OM) in Head and Neck Cancer (HNC) patients have completed therapy and the last patient post-treatment follow-up examination is scheduled for next week."

For beginners the difference between these statements is clear. I was very curious about the Oct 2nd PR and actually reached out to the company because I was confused if that meant the trial was completed and the additional 4 weeks of follow-up was part of that statement: " completed study treatment " So now today made it crystal clear that "...patients have completed therapy and the last patient post-treatment follow-up examination is scheduled for next week."

Now we officially know that dosing was completed and reported on the OCT 2nd PR and the company now informed us that the FINAL patient is to recieve their last follow-up visit via the 4 additional week protocol next week - CLOSING the trial. The PR also states the "...Company will focus on the process of concluding the study, including closing clinical sites and aggregating and analyzing data. Innovation Pharmaceuticals anticipates reporting topline results later this quarter."

The PR also goes into much more detail on the OM market and emphasizes the fact there is no approved PREVENTATIVE drug.

LEO - thank you for the clarification on the study follow-up end.

TIC TOC - this trial will hopefully return 70-90% SOM preventive rates. Which will be the best results this world has ever seen in trial results. I have done extensive research over the last week and I have seen nothing even close to that number. If those numbers come in...we will be granted BreakThrough designation and I believe that will be a milestone payment for a deal that WILL be inked shortly after the results are published publicly.

GET READY FRIENDS/LONGS!!!! We are in for an exciting end of year and 2018!!!!!!!!!!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News